Karen McLoughlin

Board Director

Director

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 1 buy · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€53k

▼ Sales (0 ops.)

—

Latest filing published 16 Jun 2026 for BEST BUY CO INC. Read the official filing

Filing timeline

BuySale

Karen McLoughlin

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Karen McLoughlin: trading record in brief

Karen McLoughlin, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Agilon Health, Inc. and Best Buy Co Inc. The record holds 12 filings, for trades running from 16 June 2021 to 12 June 2026.

Every open-market trade on record is a purchase: 1 purchase worth €53k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 11 share grants.

The record was last updated on 16 June 2026 with a share grant in Best Buy Co Inc. The last purchase on record was published on 13 December 2024, which is 674 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.